We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

127 hedge funds and large institutions have $576M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2015 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 55 increasing their positions, 43 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 43

3% less funds holding

Funds holding: 131127 (-4)

6% less capital invested

Capital invested by funds: $614M → $576M (-$38.1M)

14% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 21

Holders
127
Holders Change
-4
Holders Change %
-3.05%
% of All Funds
3.38%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
55
Reduced
43
Closed
21
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
+$1.25M
Name Holding Trade Value Shares
Change
Change in
Stake
Wellington Management Group
51
Wellington Management Group
Massachusetts
$1.41M -$241K -9,100 -13%
CIP
52
Convergence Investment Partners
Florida
$1.41M +$497K +18,790 +45%
California Public Employees Retirement System
53
California Public Employees Retirement System
California
$1.4M
Asset Management One
54
Asset Management One
Japan
$1.28M
Deutsche Bank
55
Deutsche Bank
Germany
$1.22M -$911K -34,427 -40%
Prudential Financial
56
Prudential Financial
New Jersey
$1.18M -$135K -5,100 -9%
Thrivent Financial for Lutherans
57
Thrivent Financial for Lutherans
Minnesota
$1.18M
SFM
58
Sphera Funds Management
Israel
$1.16M +$1.32M +50,000 New
CCMH
59
Cornerstone Capital Management Holdings
New York
$1.05M -$596K -22,502 -33%
QI
60
QS Investors
New York
$1.03M -$572K -21,600 -33%
GCP
61
GSA Capital Partners
United Kingdom
$1.02M +$1.16M +43,904 New
Public Sector Pension Investment Board (PSP Investments)
62
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$992K +$4.98K +188 +0.4%
California State Teachers Retirement System (CalSTRS)
63
California State Teachers Retirement System (CalSTRS)
California
$928K -$15.9K -600 -1%
ARTA
64
A.R.T. Advisors
New York
$904K +$22.2K +839 +2%
CS
65
Credit Suisse
Switzerland
$902K -$643K -24,277 -38%
Balyasny Asset Management
66
Balyasny Asset Management
Illinois
$897K +$1.02M +38,600 New
VOYA Investment Management
67
VOYA Investment Management
Georgia
$879K +$624K +23,573 +166%
AA
68
AlphaMark Advisors
Kentucky
$762K +$144K +5,425 +20%
AllianceBernstein
69
AllianceBernstein
Tennessee
$751K -$66.2K -2,500 -7%
NG
70
NatWest Group
United Kingdom
$727K -$192K -7,263 -19%
ProShare Advisors
71
ProShare Advisors
Maryland
$710K +$110K +4,154 +16%
TI
72
Turner Investments
Pennsylvania
$706K +$804K +30,360 New
AI
73
Analytic Investors
California
$668K +$188K +7,094 +33%
CIA
74
Capital Impact Advisors
Massachusetts
$665K +$570K +21,525 +305%
BG
75
BlackRock Group
United Kingdom
$655K +$53.2K +2,010 +8%

SGNT Hedge Fund Activity: Q1 2015 in Review

127 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q1 2015, worth a combined $576M — down 6.2% from $614M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of SGNT and 18 opened new positions — a net loss of 3 holders — while 43 trimmed existing stakes and 55 added.

The largest buyer was Pictet Asset Management (UK), adding an estimated $18M. The largest seller was Morgan Stanley, cutting an estimated $53.1M.

  • 127 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q1 2015, down from 131 in Q4 2014.
  • Funds reported $576M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q1 2015, down 6.2% quarter-over-quarter.
  • 18 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q1 2015 and 21 closed out, a net change of -3 holders.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q1 2015 was Pictet Asset Management (UK), an estimated $18M added.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q1 2015 was Morgan Stanley, an estimated $53.1M sold.

Based on aggregated 13F filings for Q1 2015.